CO
Cardiff Oncology Inc
🇩🇪XFRA.XE7CGermanyHealthcare
€1.17EURup +0.09 (+8.33%)OpenEnd of day6:07 PM
Price€1.17+0.09 (+8.33%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US14147L1089
- CUSIP
- Not reported
Company
- Employees
- 30
- Headquarters
- San Diego, United States
- CEO
- Dr. Mani Mohindru Ph.D.
Market
- Shares outstanding
- 67.4M
- Market cap
- €78.81M
Highlights
- Market cap
- €78.81M
- EPS LTM
- -$0.59
- P/E LTM
- -2.20
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $508K-6.96%down year on year
- Net income
- -$40.05M+21.5%up year on year
- Gross margin
- 12.6%+100.33%up year on year
- Free cash flow
- -$40.92M+2.28%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.